HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...
A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...
The U.S. Food and Drug Administration has approved a new dose of the GLP-1 class weight loss drug Wegovy that’s three times the size of the previous maximum dose. Known as “We ...
The following article was originally published in Preventing Infection in Ambulatory Care, the quarterly e-publication from the Association for Professionals in Infection Control and Epidemiology ...
For the millions of people using glucagon-like peptide-1 receptor agonists (GLP-1), a dose has long meant a weekly appointment with a needle. With the U.S. Food and Drug Administration (FDA) approving ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden administration announced October 21. The news comes just weeks after it was announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results